Gilead Sciences, Inc. (GILD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.64B | 19.89B | 17.87B | 14.72B | 16.9B | 19.17B | 14.78B | 12.32B | 14.04B | 16.09B | 15.98B | 14.29B |
| Cash & Short-Term Investments | 9.82B | 10.61B | 7.35B | 5.21B | 7.93B | 11.57B | 6.7B | 4.2B | 6.06B | 8.35B | 6.86B | 6.67B |
| Cash Only | 7.63B | 7.56B | 7.33B | 5.14B | 7.93B | 9.99B | 5.04B | 2.77B | 4.72B | 6.08B | 5.71B | 5.7B |
| Short-Term Investments | 2.19B | 3.04B | 19M | 69M | 0 | 1.58B | 1.66B | 1.43B | 1.34B | 2.27B | 1.16B | 963M |
| Accounts Receivable | 4.74B | 4.91B | 5.09B | 4.78B | 4.39B | 4.42B | 4.59B | 4.66B | 4.67B | 4.66B | 4.79B | 4.23B |
| Days Sales Outstanding | 62.42 | 58.1 | 58.48 | 58.92 | 59.45 | 54.74 | 56.4 | 61.07 | 63.49 | 61.1 | 58.85 | 57.86 |
| Inventory | 1.91B | 4.37B | 1.78B | 1.82B | 1.76B | 1.71B | 1.87B | 2.03B | 1.85B | 1.79B | 1.66B | 1.63B |
| Days Inventory Outstanding | 195.63 | 174.28 | 105.84 | 108.64 | 101.37 | 104.13 | 113.83 | 114.31 | 106.71 | 75.93 | 96.88 | 101.25 |
| Other Current Assets | 2.17B | 0 | 3.65B | 2.9B | 2.83B | 995M | 1.63B | 1.43B | 1.46B | 1.29B | 2.66B | 1.76B |
| Total Non-Current Assets | 37.64B | 39.14B | 40.66B | 41.01B | 39.53B | 39.82B | 39.74B | 41.26B | 42.25B | 46.04B | 46.39B | 48.05B |
| Property, Plant & Equipment | 5.64B | 5.61B | 5.5B | 5.46B | 5.42B | 5.41B | 5.39B | 5.35B | 5.32B | 5.32B | 5.57B | 5.54B |
| Fixed Asset Turnover | 1.24x | 1.43x | 1.42x | 1.30x | 1.23x | 1.40x | 1.41x | 1.30x | 1.26x | 1.31x | 1.27x | 1.20x |
| Goodwill | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B | 8.31B |
| Intangible Assets | 16.38B | 16.98B | 17.97B | 18.57B | 19.35B | 19.95B | 20.55B | 22.83B | 23.43B | 26.45B | 27.15B | 27.75B |
| Long-Term Investments | 1.68B | 0 | 2B | 1.91B | 684M | 0 | 730M | 710M | 1.14B | 2.16B | 1.16B | 1.33B |
| Other Non-Current Assets | 3.86B | 8.24B | 4.87B | 4.03B | 3.19B | 6.15B | 4.76B | 4.06B | 4.04B | 3.8B | 4.2B | 5.11B |
| Total Assets | 56.28B | 59.02B | 58.53B | 55.72B | 56.43B | 58.99B | 54.52B | 53.58B | 56.29B | 62.13B | 62.37B | 62.34B |
| Asset Turnover | 0.12x | 0.13x | 0.14x | 0.13x | 0.12x | 0.13x | 0.14x | 0.13x | 0.11x | 0.11x | 0.11x | 0.11x |
| Asset Growth % | -0.28% | 0.05% | 7.35% | 4% | 0.25% | -5.04% | -12.58% | -14.05% | -9.02% | -1.66% | -0.29% | -0.85% |
| Total Current Liabilities | 9.48B | 11.81B | 12.3B | 11.19B | 12.34B | 12B | 11.72B | 10.78B | 13.02B | 11.28B | 11.95B | 13.96B |
| Accounts Payable | 645M | 0 | 808M | 582M | 737M | 833M | 903M | 537M | 622M | 550M | 586M | 622M |
| Days Payables Outstanding | 40.17 | - | 40.75 | 39.98 | 45.88 | 50.51 | 42.08 | 34.15 | 34.36 | 25 | 35.51 | 39.41 |
| Short-Term Debt | 1.31B | 0 | 2.81B | 2.81B | 2.81B | 1.81B | 1.81B | 1.81B | 3.67B | 1.8B | 1.79B | 4.04B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.52B | 11.81B | 3.75B | 3.59B | 4.62B | 3.71B | 3.36B | 3.25B | 3.27B | 3.8B | 3.77B | 3.58B |
| Current Ratio | 1.97x | 1.68x | 1.45x | 1.32x | 1.37x | 1.60x | 1.26x | 1.14x | 1.08x | 1.43x | 1.34x | 1.02x |
| Quick Ratio | 1.77x | 1.31x | 1.31x | 1.15x | 1.23x | 1.45x | 1.10x | 0.95x | 0.94x | 1.27x | 1.20x | 0.91x |
| Cash Conversion Cycle | 217.88 | - | 123.56 | 127.58 | 114.94 | 108.36 | 128.14 | 141.22 | 135.84 | 112.03 | 120.22 | 119.7 |
| Total Non-Current Liabilities | 23.37B | 24.59B | 24.78B | 24.94B | 25.01B | 27.75B | 24.41B | 24.6B | 25.82B | 28.1B | 28.19B | 27.28B |
| Long-Term Debt | 20.86B | 24.59B | 22.14B | 22.14B | 22.15B | 24.9B | 21.44B | 21.54B | 21.53B | 23.19B | 23.19B | 21.21B |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 498M | 0 | 0 | 0 | 546M | 0 | 0 |
| Deferred Tax Liabilities | 392M | 0 | 597M | 652M | 709M | 724M | 794M | 907M | 933M | 1.59B | 1.98B | 2.11B |
| Other Non-Current Liabilities | 2.12B | 0 | 2.05B | 2.15B | 2.16B | 1.63B | 2.18B | 2.15B | 3.36B | 2.77B | 3.01B | 3.96B |
| Total Liabilities | 32.85B | 36.41B | 37.08B | 36.13B | 37.36B | 39.75B | 36.13B | 35.38B | 38.84B | 39.38B | 40.13B | 41.24B |
| Total Debt | 22.17B | 24.59B | 24.94B | 24.95B | 24.95B | 27.32B | 23.25B | 23.35B | 25.19B | 25.66B | 24.98B | 25.25B |
| Net Debt | 14.55B | 17.03B | 17.61B | 19.8B | 17.03B | 17.33B | 18.21B | 20.58B | 20.48B | 19.57B | 19.28B | 19.54B |
| Debt / Equity | 0.95x | 1.09x | 1.16x | 1.27x | 1.31x | 1.42x | 1.26x | 1.28x | 1.44x | 1.13x | 1.12x | 1.20x |
| Debt / EBITDA | 9.43x | 6.69x | 6.22x | 7.88x | 8.51x | 8.69x | 14.73x | 7.00x | - | 11.16x | 7.55x | 10.76x |
| Net Debt / EBITDA | 6.19x | 4.63x | 4.39x | 6.26x | 5.80x | 5.51x | 11.54x | 6.16x | - | 8.51x | 5.83x | 8.33x |
| Interest Coverage | 9.80x | 9.15x | 15.22x | 10.56x | 7.34x | 9.70x | 5.02x | 9.66x | -16.66x | 7.56x | 10.99x | 7.90x |
| Total Equity | 23.43B | 22.62B | 21.46B | 19.59B | 19.08B | 19.25B | 18.39B | 18.2B | 17.45B | 22.75B | 22.24B | 21.09B |
| Equity Growth % | 22.82% | 17.52% | 16.67% | 7.66% | 9.3% | -15.4% | -17.31% | -13.73% | -16.64% | 7.26% | 5.62% | 4.34% |
| Book Value per Share | 18.69 | 18.05 | 17.11 | 15.61 | 15.15 | 15.29 | 14.67 | 14.55 | 14.00 | 18.11 | 17.69 | 16.77 |
| Total Shareholders' Equity | 23.52B | 22.62B | 21.54B | 19.68B | 19.16B | 19.33B | 18.47B | 18.28B | 17.54B | 22.83B | 22.31B | 21.16B |
| Common Stock | 1M | 22.62B | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | 14.13B | 0 | 12.82B | 11.32B | 10.93B | 11.5B | 11.07B | 11.16B | 10.66B | 16.3B | 16B | 15.14B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 78M | 0 | 36M | -18M | 92M | 132M | 73M | 93M | 69M | 28M | 31M | 10M |
| Minority Interest | -84M | 0 | -84M | -84M | -84M | -84M | -84M | -84M | -84M | -84M | -72M | -64M |